Similarly, corticosteroid treatment was more frequent in groups B and C, and cardiac treatment with ACE-inhibitors, β-blockers and diuretics was more frequent in advanced DMD patients. The gene discussed is ACE; the disease is Duchenne muscular dystrophy.